RONDA TOOLE: Open Payments
NPI 1467491290 · PANAMA CITY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 42 payments from 11 companies in 2025. Trend: 2023 $556 · 2024 $606 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $212 |
| ABBVIE INC. | 14 | $201 |
| Lilly USA, LLC | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Abbott Laboratories | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Amgen Inc. | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, ZEPBOUND, Wegovy, AIRSUPRA, UBRELVY, FREESTYLE LIBRE 3, Ozempic.
Industry payments across FL — which companies pay providers there.
